Capital Asset Advisory Services LLC Spero Therapeutics, Inc. Transaction History
Capital Asset Advisory Services LLC
- $2.3 Billion
- Q3 2025
A detailed history of Capital Asset Advisory Services LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 32,548 shares of SPRO stock, worth $78,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,548
Previous 32,548
-0.0%
Holding current value
$78,440
Previous $94,000
35.11%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SPRO
# of Institutions
51Shares Held
10.6MCall Options Held
0Put Options Held
65.7K-
Vanguard Group Inc Valley Forge, PA1.99MShares$4.8 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.6MShares$3.86 Million0.5% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.45MShares$3.5 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.26 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.14 Million0.1% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $84.5M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...